| Q40108226 | 1 The Chemotherapy of Leprosy |
| Q40791589 | A Culturable Mycobacterium Isolated from Leproma of a Leprosy-Transmitted Armadillo |
| Q70411683 | A dual effect of tilorone on multiplication of Mycobacterium leprae in mice |
| Q70111524 | A transmissible agent from sarcoid tissue |
| Q33983346 | Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice. |
| Q28476689 | Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice |
| Q33980444 | Activities of several antimicrobials against Mycobacterium ulcerans infection in mice. |
| Q44392071 | Activities of sitafloxacin (DU-6859a), either singly or in combination with rifampin, against Mycobacterium ulcerans infection in mice |
| Q54487709 | Activity of ansamycin against Mycobacterium leprae in mice |
| Q22305432 | Advances and hurdles on the way toward a leprosy vaccine |
| Q70137981 | Agent transmissible from Crohn's disease tissue |
| Q36771957 | An attempt to demonstrate a transmissible agent from sarcoid material |
| Q54474353 | Ansamycin activity against rifampicin-resistant Mycobacterium leprae |
| Q36313776 | Antigen-specific cellular and humoral responses are induced by intradermal Mycobacterium leprae infection of the mouse ear. |
| Q90154838 | Armadillos and leprosy: from infection to biological model |
| Q34510451 | Bactericidal activities of R207910 and other newer antimicrobial agents against Mycobacterium leprae in mice |
| Q28487137 | Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of Mycobacterium ulcerans disease |
| Q34144367 | Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice |
| Q54484587 | Biological activities of a murine T-cell clone with reactivity to Mycobacterium leprae |
| Q38168225 | Biological, chemical, immunological and staining properties of bacteria isolated from tissues of leprosy patients |
| Q70386637 | Cell-mediated immunity in mice treated with Mycobacterium leprae or with macrophages harbouring M. leprae |
| Q68202764 | Cellular immune response to the cell walls of Mycobacterium leprae in leprosy patients and healthy subjects exposed to leprosy |
| Q72713210 | Characterization and Functional Studies of the Murine T-Lymphocyte Response to Mycobacterium leprae Antigen |
| Q36769909 | Chemical Characterization of Organisms Isolated from Leprosy Patients |
| Q34001085 | Chemotherapy in Leprosy |
| Q34721670 | Chemotherapy of lepromatous leprosy: Recent developments and prospects for the future |
| Q69895205 | Cultivable mycobacteria isolated from organs of armadillos uninoculated and inoculated with Mycobacterium leprae |
| Q36676399 | Current concepts in the pathogenesis of leprosy. Clinical, pathological, immunological and chemotherapeutic aspects |
| Q72102374 | Detection of Mycobacterium leprae DNA in formalin-fixed, paraffin-embedded samples from multibacillary and paucibacillary leprosy patients by polymerase chain reaction |
| Q28481688 | Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test |
| Q53931797 | Detection of gene mutations related with drug resistance in Mycobacterium leprae from leprosy patients using Touch-Down (TD) PCR. |
| Q42283121 | Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosy. |
| Q53788395 | Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1. |
| Q58436192 | Drugs for Tropical Diseases in the Third World |
| Q40255882 | EFFECT OF ENVIRONMENTAL TEMPERATURES ON INFECTION WITH MYCOBACTERIUM MARINUM (BALNEI) OF MICE AND A NUMBER OF POIKILOTHERMIC SPECIES |
| Q53772535 | Editorial Commentary: Drug-Resistance in Leprosy: Moving Toward Understanding the Scope of the Problem and How to Tackle It. |
| Q70004949 | Effect of bran on blood lipids and calcium |
| Q34714944 | Effect of vaccination with refined components of the organism on infection of mice with Mycobacterium leprae |
| Q67499915 | Electrophoretic patterns of serum proteins and immunoglobulin levels in mycobacterial infections--studies in mice infected with mycobacterium leprae and mycobacterium lepraemurium |
| Q71208417 | Enhanced Susceptibility of Thymectomized and Irradiated Mice to Infection with Mycobacterium leprae |
| Q44662466 | Enhancing Effect of Antilymphocytic Globulin on Human Leprosy Infection in Thymectomized Mice |
| Q53771318 | Enhancing effect of antilymphocytic serum on mycobacterial infections in mice. |
| Q34056391 | Evaluation of qPCR-based assays for leprosy diagnosis directly in clinical specimens |
| Q59062474 | Experimental Lepromatous Leprosy |
| Q70286740 | Experimental Transmission of a Feline Mycobacterial Skin Disease (Feline Leprosy) |
| Q36536269 | Experimental infection of mice with Mycobacterium leprae hominis: additional data |
| Q43671612 | Experimental reproduction of the Jorge Lobo's disease in BAlb/c mice inoculated with Lacazia loboi obtained from a previously infected mouse |
| Q67842893 | Factors Influencing thein vitroGrowth ofMycobacterium leprae: Effect of Oxygen |
| Q70284469 | Gaschromatography of Constitutive Fatty Acids inMycobacterium leprae |
| Q36498586 | Gene Transfer in Mycobacterium tuberculosis: Shuttle Phasmids to Enlightenment. |
| Q72561495 | Glutamic acid decarboxylase in Mycobacterium leprae |
| Q44366457 | Hairless mice, human leprosy and thymus-derived-lymphocytes |
| Q93793202 | Histological changes evoked in mice by Freund's complete adjuvant |
| Q58461882 | IFN-γ and NO in mycobacterial disease: new jobs for old hands |
| Q36266539 | IMMUNOLOGICAL IDENTIFICATION OF FOOT-PAD ISOLATES AS MYCOBACTERIUM LEPRAE BY LEPROMIN REACTIVITY IN LEPROSY PATIENTS. |
| Q38316314 | Identification of Mycobacterium species by comparative analysis of the dnaA gene |
| Q72154730 | Immune response to Mycobacterium leprae: further studies on the assessment of humoral immune response in mice |
| Q73156670 | Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R |
| Q40289763 | Immunology of leprosy |
| Q64961192 | Immunoregulatory Defects in Leprosy |
| Q69341165 | Impact of cool temperatures on transformation of human and armadilio lymphocytes (Dasypus novemcinctus, Linn.) as related to leprosy |
| Q93566586 | Importance of the footpad lesion in the mouse response to local inoculation of Mycobacterium marinum |
| Q90603894 | In Vivo Imaging of Bioluminescent Mycobacterium ulcerans: A Tool to Refine the Murine Buruli Ulcer Tail Model |
| Q43868914 | In vivo activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with dapsone, against Mycobacterium leprae |
| Q44379584 | Incidations for thalidomide therapy for leprosy |
| Q38071240 | Insights from animal models on the immunogenetics of leprosy: a review |
| Q90391712 | Investigating Evolutionary Rate Variation in Bacteria |
| Q67726688 | Leprosy |
| Q72369243 | Leprosy |
| Q79919272 | Leprosy |
| Q71486274 | Leprosy and tuberculosis |
| Q37799282 | Leprosy as a genetic disease |
| Q37076135 | Leprosy as a genetic model for susceptibility to common infectious diseases |
| Q53564819 | Leprosy control in the Northern Territory. |
| Q40928600 | Leprosy in a Chimpanzee: Morphology of the Skin Lesions and Characterization of the Organism |
| Q40451059 | Leprosy in red squirrels. |
| Q61798621 | Leprosy survey among rural communities and wild armadillos from Amazonas state, Northern Brazil |
| Q39482434 | Leprosy: new insight into an ancient disease |
| Q37164550 | Lymphotoxin-alpha and TNF have essential but independent roles in the evolution of the granulomatous response in experimental leprosy |
| Q72580096 | Metaraminol provocation test for familial Mediterranean fever |
| Q39654273 | Mutations in the drug resistance-determining region of Mycobacterium lepromatosis isolated from leprosy patients in Mexico |
| Q56270926 | Mycobacterium leprae |
| Q34494709 | Mycobacterium leprae and leprosy: a compendium |
| Q54276499 | Mycobacterium leprae in six-banded (Euphractus sexcinctus) and nine-banded armadillos (Dasypus novemcinctus) in Northeast Brazil. |
| Q36911234 | New prospects for the study of leprosy in the laboratory |
| Q33650815 | Ocular histopathology in animals experimentally infected with Mycobacterium leprae and M. lepraemurium. 1. Mycobacterium leprae and M. lepraemurium infections in the mouse. 2. Mycobacterium leprae infections in the 9-banded armadillo (Dasypus novemc |
| Q44419057 | Oral manifestations of leprosy |
| Q28537722 | PCR-based techniques for leprosy diagnosis: from the laboratory to the clinic |
| Q40175720 | Pathology and pathogenesis of predilective sites of nerve damage in leprous neuritis. Nerves in the arm and the face |
| Q36679812 | Popliteal lymph node (PLN) assay to study adjuvant effects on respiratory allergy |
| Q76456879 | Present Perspectives in Leprosy |
| Q53794046 | Progress in Leprosy |
| Q34298351 | Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis |
| Q38217535 | Realities of leprosy control: updating scenarios |
| Q39616941 | Recent advances and present trends in leprosy research |
| Q34310205 | Recombinant BCG vaccines |
| Q39692394 | Reconstructive surgery for Hansen's disease (leprosy) |
| Q42949894 | Recurrence of leprosy cases in the State of Mato Grosso, Central-West Brazil |
| Q40245375 | Relation of Infection to Tissue Temperature in Mice Infected with Mycobacterium marinum and Mycobacterium leprae |
| Q76934771 | SULPHONE RESISTANCE IN LEPROSY |
| Q72565085 | Sheffield isolates are Haemophilus ducreyi |
| Q44620654 | Site of multiplication of human leprosy bacilli inoculated into the foot-pads of mice |
| Q33581556 | Socioeconomics of a global leprosy eradication programme |
| Q40802668 | Some aspects of the pathogenesis and pathomorphology of leprosy |
| Q36720246 | Some recent laboratory findings on Mycobacterium leprae. Implications for the therapy, epidemiology and control of leprosy |
| Q44949121 | Staphylococcal Footpad Infection in Mice |
| Q28552736 | Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice |
| Q38360672 | Systematic review: Whipple's disease (Tropheryma whipplei infection) and its unmasking by tumour necrosis factor inhibitors |
| Q99633705 | Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses |
| Q74465037 | The activity of rifabutin against Mycobacterium leprae in armadillos |
| Q34152302 | The armadillo as a model for peripheral neuropathy in leprosy |
| Q34316512 | The armadillo: a model for the neuropathy of leprosy and potentially other neurodegenerative diseases |
| Q39998955 | The changing pattern of granulomas of the upper respiratory tract |
| Q24545809 | The continuing challenges of leprosy |
| Q39059002 | The control of infective skin diseases--the lessons of leprosy research |
| Q55243430 | The distribution of bacterial doubling times in the wild. |
| Q47789536 | The effect of several rates of freezing and thawing on the viability of Mycobacterium leprae |
| Q47742622 | The fate ofMycobacterium leprae in CBA mice |
| Q39156402 | The first decade in experimental leprosy. |
| Q34374955 | The hamster cheek pouch: an immunologically privileged site suitable to the study of granulomatous infections |
| Q52545418 | The study of Mycobacterium leprae infection in interferon-gamma gene--disrupted mice as a model to explore the immunopathologic spectrum of leprosy. |
| Q43742636 | The use of an amino acid as a precursor of a bioactive metabolite in combatting an infectious disease: The efficacy of a tryptophan-enriched diet in the treatment of leprosy |
| Q39593954 | Therapeutic Effect of Intravenously Administered Yeast Glucan, in Mice Locally Infected by Mycobacterium Leprae |
| Q39500272 | Therapeutic effect of yeast glucan in mice infected with Mycobacterium leprae [proceedings] |
| Q61443627 | Ticks as potential vectors of Mycobacterium leprae: Use of tick cell lines to culture the bacilli and generate transgenic strains |
| Q69905087 | Transmisjsion of human leprosy to the mouse and its clinical implications |
| Q67045849 | Transmission of human leprosy bacteria to hedgehogs |
| Q35625819 | Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife? |
| Q34753203 | Whipple's disease: new aspects of pathogenesis and treatment |
| Q34298426 | rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B. |